+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative safety of atypical antipsychotics and the risk of pneumonia in the elderly

Comparative safety of atypical antipsychotics and the risk of pneumonia in the elderly

Pharmacoepidemiology and Drug Safety 24(12): 1271-1280

Previous studies have documented increased risk of pneumonia with antipsychotic use in the elderly; however, differential risk across individual atypical antipsychotics remains unaddressed. This study examines the effect of individual atypical antipsychotics on risk of pneumonia in elderly patients. This retrospective cohort study was conducted using a large claims database. The study population included new users of atypical antipsychotics (≥65 years). The multiple propensity-score adjusted survival model was used to examine risk of pneumonia within a 1-year follow-up period. A total of 92 234 patients newly prescribed atypical antipsychotic medication were identified. Of these, 41 780 (45.30%) were quetiapine users, 31 048 (33.66%) risperidone users, 11 375 (12.33%) olanzapine users, 6790 (7.36%) aripiprazole users, and 1241 (1.35%) ziprasidone users. Within the 1-year follow-up period, 12 411 (13.46%) patients taking atypical antipsychotics had a diagnosis of pneumonia. The multiple propensity-score-adjusted survival model revealed increased risk of pneumonia with the use of risperidone (hazard ratios (HR) 1.14, 95%CI 1.10-1.18) and olanzapine (HR 1.10, 95%CI 1.04-1.16) compared with the use of quetiapine. This large population-based study suggests that use of risperidone and olanzapine increases risk of pneumonia compared with use of quetiapine in elderly patients. This study provides new information on the comparative risk of pneumonia associated with different atypical antipsychotics in the elderly to support optimal treatment decisions.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057458940

Download citation: RISBibTeXText

PMID: 26445931

DOI: 10.1002/pds.3882

Related references

Risk of pneumonia in elderly nursing home residents using typical versus atypical antipsychotics. Annals of PharmacoTherapy 47(4): 464-474, 2014

Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?. Pharmacological Research 59(1): 1-12, 2008

Atypical antipsychotics, elderly patients, and mortality risk. Southern Medical Journal 100(10): 964-965, 2007

Managing risk when considering the use of atypical antipsychotics for elderly patients with dementia-related psychosis. Journal of Psychiatric Practice 13(3): 143-152, 2007

Prevalence of pre-existing risk factors for adverse events associated with atypical antipsychotics among commercially insured and medicaid insured patients newly initiating atypical antipsychotics. Current Drug Safety 9(3): 227-235, 2015

Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study. Journal of Clinical Psychiatry 68(6): 929-934, 2007

Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. American Journal of Psychiatry 173(3): 263-270, 2016

Comparative safety of antipsychotics: another look at the risk of diabetes. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 58(4): 218-224, 2013

Increased risk of cerebrovascular adverse events and death in elderly demented patients treated with atypical antipsychotics: what's a clinician to do?. Journal of Clinical Psychiatry 66(8): 1071-1071, 2005

Atypical antipsychotics and the risk of diabetes in an elderly population in long-term care: a retrospective nursing home chart review study. Journal of the American Medical Directors Association 10(2): 115-119, 2009

Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics. Journal of Managed Care Pharmacy 18(9): 676-689, 2013

Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature. Journal of Psychopharmacology 24(7): 1121-1125, 2010

Atypical antipsychotics in the elderly. International Journal of Psychiatry in Clinical Practice 5(4): 257-261, 2001

Use of atypical antipsychotics in the elderly. Psychiatry: 28-31, 2008

The emerging role of atypical antipsychotics in the treatment of tardive dyskinesia induced by other atypical antipsychotics. Journal of Clinical Psychiatry 72(7): 1016; Author Reply 1016-7, 2011